Amaç: Dissemine intravasküler koagülasyon (DİK) çocuk yoğun bakım ünitesinde (ÇYBÜ) görülen en ciddi hemostatik problemlerden biridir. Tedavide ana amaç altta yatan hastalığın tedavisi olmakla birlikte antioksidan ilaçların rolü tartışmalıdır. Çalışmada DİK tespit edilen kritik hastalarda vitamin E, selenyum ve glutatyon peroksidaz (GPx) aktivitesini değerlendirmeyi amaçladık.Gereç ve Yöntemler: Bu çalışmaya Eylül 2011- Ekim 2013 tarihleri arasında ÇYBÜ’de DİK tanısı alan 150 hasta alındı. ÇYBÜ’ne kabul öncesi son 24 saat içinde kan transfüzyonu yapılan olgular çalışma dışı bırakıldı. DİK skorları International Society on Thrombosis and Haemostasis (ISTH) sistemine göre hesaplanarak 2 gruba (DİK <5 ve DİK ≥ 5) ayrıldı. Hastaların yaş, cinsiyet, yoğun bakıma yatış tanısı, Pediatric Risk of Mortality (PRISM) ve Pediatric Logistic Organ Dysfunction (PELOD) skorları, yoğun bakımda yatış süreleri kaydedildi.Bulgular: Çalışmaya alınan olguların 78’si erkek, 72’si kız olup ortanca yaşları 50 ay (12-106 ay)’di. Tüm olguların vitamin E düzeyi 9.7±2.8 mg/L, selenyum düzeyi 67.8±36.5 μg/L ve GPx aktivitesi ise 82.9±44.3 U/L olarak ölçüldü. DİK ≥5 olan grupta sırasıyla vitamin E, selenyum ve GPx aktivitesi DİK< 5 olan gruba göre anlamlı düzeyde düşük bulundu (p<0.01, p<0.001, p<0.001). DİK tespit edilen hastalar sepsis ve sepsis dışı olgular olarak ikiye ayrılıp selenyum, vitamin E ve GPx aktivitesi değerlendirildiğinde ise sepsis grubunda sırasıyla anlamlı düzeyde düşük olarak saptandı (p=0.003, p=0.044, , p=0.007).Sonuç: DİK tespit edilen kritik hasta çocuklarda plazma selenyum, vitamin E ve GPx aktivitesi düşüktür. Bu durum sepsisli hastalarda çok daha belirgindir. DİK ve sepsis tespit edilen hastalar başta olmak üzere vitamin E ve selenyum desteğinin yapılmasının yararlı olacağını düşünmekteyiz. Tedavi algoritmalarını geliştirmek için daha geniş hasta sayıları içeren prospektif klinik çalışmalar gereklidir.
Objective: Disseminated intravascular coagulation (DIC) is one of the most serious hemostatic abnormalities in the pediatric intensive care unit (PICU). The primary treatment for DIC is correction of the underlying disease while the role of antioxidant therapy is controversial. In this study, we aimed to evaluate the levels of vitamin E, selenium and glutathione peroxidase (GPx) activity in DIC patients.Material and Methods: Between September 2011 and October 2013, 150 patients diagnosed with DIC in the PICU were enrolled in this study. Patients who received blood transfusion within 24 hours before admission to the PICU were excluded. The DIC score was calculated according to the International Society on Thrombosis and Haemostasis diagnostic scoring system, and patients were divided into two groups according to their DIC score (DIC< 5 and DIC ≥5). GİrİŞ Demographic data, age, gender, initial diagnosis, Pediatric Risk of Mortality (PRISM) and Pediatric Logistic Organ Dysfunction (PELOD) scores, selenium, vitamin E levels and GPx activity, were evaluated.results: Participants included 78 boys and 72 girls with a median age of 50 months (12-106 months). In all patients, selenium, vitamin E levels, and GPx were 67.8±36.5 µg/L, 9.7±2.8 mg/L and 82.9±44.3 U/L respectively. Vitamin E, selenium and GPx were significantly lower in the DIC ≥ 5 group (p<0.01, p<0.001 and p<0.001, respectively). We further divided the patients with scores of DIC ≥ 5 into two groups, and the sepsis group had significantly lower selenium, vitamin E, levels and GPx activity (p=0.003, p=0.044, and p=0.007, respectively).conclusion: In patients with DIC, plasma selenium and vitamin E levels and GPx activity were significantly lower in critically ill children. This was more prominent in those with sepsis. We believe that vitamin E and selenium supplementation is useful in treating critically ill patients with DIC, especially those with sepsis. In order to develop treatment algorithms, prospective clinical studies with a larger patient population are warranted
Other ID | JA87SP94EB |
---|---|
Journal Section | Research Article |
Authors | |
Publication Date | December 1, 2017 |
Submission Date | December 1, 2017 |
Published in Issue | Year 2017 Volume: 11 Issue: 4 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.